US Injectable Drug Delivery Devices Market

US Drug Delivery Devices Market Research Report: Size, Share, Trend Analysis By Drug Delivery Route (Oral, Injectable, Transdermal, Inhalation, Implantable), By Device Type (Syringes, Pumps, Inhalers, Patch Delivery Systems, Nebulizers), By Applications (Diabetes, Cancer, Cardiovascular, Autoimmune Disorders, Pain Management) and By End Users (Hospitals, Homecare, Pharmaceutical Companies, Research Institutions) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
7.37%
2024 Market Size
$ 27 Billion
2035 Market Size
$ 59 Billion
Medical Device ● Updated April 2026 Report ID: MRFR/MED/17849-HCR | Pages: 100 | Author: Nidhi Mandole, Rahul Gotadki
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Device Type (USD Billion)
      1. 4.1.1 Conventional Injection Devices
      2. 4.1.2 Self-Injection Devices
    2. 4.2 Pharmaceutical, BY Therapeutic Application (USD Billion)
      1. 4.2.1 Autoimmune Diseases
      2. 4.2.2 Hormonal Disorders and Cancer
    3. 4.3 Pharmaceutical, BY Usage Pattern (USD Billion)
      1. 4.3.1 Curative Pattern
      2. 4.3.2 Immunization
    4. 4.4 Pharmaceutical, BY Site of Delivery (USD Billion)
      1. 4.4.1 Intramuscular
      2. 4.4.2 Subcutaneous
      3. 4.4.3 Intradermal
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Becton Dickinson (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 AbbVie (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Johnson & Johnson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Roche (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Syringe (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Terumo (JP)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Nipro (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Smiths Medical (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DEVICE TYPE
    3. 6.3 US MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    4. 6.4 US MARKET ANALYSIS BY USAGE PATTERN
    5. 6.5 US MARKET ANALYSIS BY SITE OF DELIVERY
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY DEVICE TYPE, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 PHARMACEUTICAL, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY THERAPEUTIC APPLICATION, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY USAGE PATTERN, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY USAGE PATTERN, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY SITE OF DELIVERY, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY SITE OF DELIVERY, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      3. 7.2.3 BY USAGE PATTERN, 2025-2035 (USD Billion)
      4. 7.2.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

US Injectable Drug Delivery Devices Market Segmentation

US Injectable Drug Delivery Devices Market By Device Type (USD Billion, 2025-2035)

  • Conventional Injection Devices
  • Self-Injection Devices

US Injectable Drug Delivery Devices Market By Therapeutic Application (USD Billion, 2025-2035)

  • Autoimmune Diseases
  • Hormonal Disorders and Cancer

US Injectable Drug Delivery Devices Market By Usage Pattern (USD Billion, 2025-2035)

  • Curative Pattern
  • Immunization

US Injectable Drug Delivery Devices Market By Site of Delivery (USD Billion, 2025-2035)

  • Intramuscular
  • Subcutaneous
  • Intradermal
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.